The report provides a detailed analysis essential for establishing a Deoxyadenosine production plant. It encompasses all critical aspects necessary for Deoxyadenosine production, including the cost of Deoxyadenosine production, Deoxyadenosine plant cost, Deoxyadenosine production costs, and the overall Deoxyadenosine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Deoxyadenosine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Deoxyadenosine is a purine nucleoside, mainly utilised as an important intermediate in pharmaceutical production. It is used to synthesise antiviral and anticancer drugs like cladribine (2-chloro-2'-deoxyadenosine), which treats multiple sclerosis and leukaemia. Additionally, it also has application as a reagent in DNA synthesis, molecular biology tools, genetic engineering, and cell culture media, with monohydrate forms used in biotech research and as biomarkers for oxidised/reduced nucleotide analogues.
Deoxyadenosine market growth is propelled by rising demand in the pharmaceutical sector for nucleoside-based therapeutics, including antiviral and anticancer drugs like cladribine for multiple sclerosis and leukaemia treatments. Advancements in biotechnology, such as personalised medicine, genomics, and nucleotide synthesis technologies, along with rising investments in biomedical R&D, drive expansion, fuelled by biopharmaceutical research and genetic engineering applications, which boost the market growth.
Moreover, robust biotech sectors in the Asia-Pacific, government support for healthcare infrastructure, and increasing needs in molecular biology reagents and regenerative medicine propel the market expansion. Industrial deoxyadenosine procurement is influenced by demands of ultra-high purity levels exceeding 99.5% HPLC, with specific limits on single impurities (<0.1%), heavy metals (<10 ppm), and microbial contaminants to prevent batch failures in nucleoside analogue synthesis like cladribine for leukaemia therapies.
Raw Material for Deoxyadenosine Production
According to the Deoxyadenosine production plant project report, the various raw materials for Deoxyadenosine production include 2,6-dichloropurine | sodium hydride or potassium tert-butoxide | anhydrous dimethylformamide (DMF) or tetrahydrofuran (THF).
Production Process of Deoxyadenosine
The extensive Deoxyadenosine production cost report consists of the following major industrial production process:
- Production via a chromatography-free Vorbrüggen glycosylation process: The production process of deoxyadenosine begins with forming alkali metal salts (sodium or potassium) of 2,6-dichloropurine using sodium hydride or potassium tert-butoxide in anhydrous DMF or THF. In the next step, the salt couples with protected 1-O-acetyl-2-deoxy-3,5-di-O-benzoyl-D-ribofuranose in solvents such as acetonitrile or MTBE at 20-80 degree Celsius, achieving β-anomer selectivity (>95%) through neighbouring group participation with yields of 85-95%. Additionally, subsequent ammonolysis with methanolic ammonia at 50-70 degree Celsius replaces chlorines with an amino group to form the adenine base, followed by benzoyl deprotection via NaOH/methanol workup. The final purification occurs through direct precipitation and recrystallisation from alcohols, ketones, or ethers, producing the product with >99.5% HPLC purity with single impurities <0.1%.
Properties of Deoxyadenosine
2'-Deoxyadenosine (C10H13N5O3, molecular weight 251.24 g/mol) is a white, odourless crystalline powder. It has a melting point in the range of 187-189 degree Celsius, with low solubility in water, DMSO, and methanol. It has a calculated logP of -0.5, indicating moderate hydrophilicity, and a pKa of 3.8 for its protonated form. It has a density of 1.29 g/cm³ and a refractive index of ~1.76. It remains stable under an inert atmosphere at 2-8 degree Celsius in the dark, often supplied as the monohydrate form (molecular weight 269.26 g/mol) for cell culture applications. These physical and chemical properties, including collision cross sections of 158-162 Ų for [M+H]+ ions in ion mobility spectrometry, make it ideal for DNA synthesis reagents and pharmaceutical intermediates requiring high purity (>99%) under GMP conditions.